✓
Open
27 Jul 2021
✓
Close
29 Jul 2021
3
Allotment
—
✓
Listing
Fri, Aug 6, 2021
Price Band
₹695 to ₹720
Issue Size
2,10,22,222 shares (agg. up to ₹1,514 Cr)
Lot Size
20 Shares
Listing Date
Fri, Aug 6, 2021
Latest GMP
₹82
Est. Gain
11.39%
✦ AI Insight
GMP Trend
06-08-2021₹82Est. ₹802+11.39%
05-08-2021₹90Est. ₹810+12.5%
04-08-2021₹83Est. ₹803+11.53%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 31.02x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|
| Assets | 1,997.08 | 1,725.60 | 1,475.40 |
| Total Income | 1,885.98 | 1,549.30 | 886.87 |
| Profit After Tax | 351.58 | 313.10 | 195.59 |
| EBITDA | 591.89 | 483.95 | 248.16 |
| NET Worth | 752.75 | 401.69 | 88.13 |
| Reserves and Surplus | 750.79 | 399.73 | 86.17 |
| Total Borrowing | 0.00 | 0.02 | 0.02 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Gland Pharma Ltd. | Mainboard | ₹6,479.55 Cr | ₹1500 | null | ₹1,819.55 | +21.30% | ₹2,959.30 |
| Walpar Nutritions Ltd. | SME | ₹6.60 Cr | ₹55 | null | ₹57.00 | +3.64% | ₹23.00 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Payment of outstanding purchase consideration to the Promoter for thespin-off of the API business from the Promoter into our Companypursuant to the Business Purchase Agreementdated October 9, 2018 | 800.00 |
| 2 | Funding the capital expenditure requirements | 152.76 |
| 3 | General corporate purposes | 57.68 |
About Glenmark Life Sciences IPO
Updated on Aug 5, 2026
Contact Details
Glenmark Life Sciences Ltd. AddressPlot No.170-172, Chandramouli Industrial EstateMohol BazarpethSolapur, Maharashtra, 413213+91 2189 234456/ +91 2189complianceofficer@glenmarklifesciences.comVisit Website